(Q42548854)

2 November 2017

Clozapine-induced electroencephalogram changes as a function of clozapine serum levels (English)

1 reference

2 November 2017

1

Freudenreich O

1 reference

2 November 2017

Weiner RD

2

1 reference

PubMed ID

9209730

2 November 2017

McEvoy JP

series ordinal

3

1 reference

PubMed ID

9209730

2 November 2017

language of work or name

English

0 references

publication date

1 July 1997

1 reference

2 November 2017

Biological Psychiatry

1 reference

2 November 2017

42

1 reference

2 November 2017

132-137

1 reference

2 November 2017

2

1 reference

Myoclonic seizures and "leg folding" phenomena with clozapine therapy: report of two cases

2 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900298-3

Clozapine-related seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900298-3

Clozapine can cause hallucinations by inducing complex partial seizures of temporal lobe origin (temporal lobe epilepsy). A potentially serious complication in the management of schizophrenia with clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900298-3

Myoclonic seizures followed by grand mal seizures during clozapine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900298-3

EEG alterations and seizures during treatment with clozapine. A retrospective study of 283 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900298-3

7 January 2021

Clozapine and seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900298-3

Influence of patient-related variables on clozapine plasma levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900298-3

EEG alterations in patients treated with clozapine in relation to plasma levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900298-3

The relationship between EEG changes and cognitive functions in dementia: a study in a VA population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900298-3

Prolonged postictal encephalopathy in two patients with clozapine-induced seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900298-3

Clinical picture and long-term course of epileptic seizures that occur during clozapine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900298-3

Spectrum of EEG abnormalities during clozapine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900298-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900298-3

Clozapine plasma levels and convulsions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900298-3

Seizure with low doses of clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900298-3

Clozapine-induced seizures and EEG changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900298-3

Seizures during clozapine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900298-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(96)00298-3

1 reference

2 November 2017

1 reference

PubMed ID

9209730